ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2265

The Effects of Message Framing on Patients’ Perceptions and Willingness to Switch to a Biosimilar

Chiara Gasteiger 1, Annie Jones 1, Maria Kleinstauber 1, Maria Lobo 2, Robert Horne 3, Keith Petrie 1 and Nicola Dalbeth1, 1University of Auckland, Auckland, New Zealand, 2Auckland District Health Board, Auckland, New Zealand, 3University College London, London, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: biosimilars and education, patient

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Patient Preferences, Beliefs, & Experiences

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients may hold negative perceptions towards biosimilars which can create barriers to their uptake. Physicians also report uncertainty in how best to explain biosimilars. The aim of this study was to measure the effect of differently framed explanations on patients’ perceptions of and willingness to switch to a biosimilar.

Methods: Ninety-six patients with rheumatic diseases taking an originator biologic were randomised to receive one of four biosimilar explanations delivered by video- positive framing with and without an analogy, and negative framing with and without an analogy. The same physician was featured in each video explanation to ensure consistency.. The positive explanation employed a positive valence attribute frame, whereby the similarities between the biologic and biosimilar were emphasised. The physician featured in the video used positive body language and verbal cues (e.g. nodding and smiling) to promote a positive interaction. Comparatively, the negatively framed explanation focused on the differences between biologics and biosimilars, and the physician used negative body language and verbal cues (e.g. less confident vocal tone) to imply uncertainty regarding efficacy and safety. The analogy used focused on the concept of baking bread, using a cheaper yeast from a different brand. Willingness to switch to a biosimilar, perceptions about biosimilars, and the effectiveness of the explanation were measured after the information delivery.

Results: Positive framing led to more participants being willing to switch (67%) than negative framing (46%). Framing significantly predicted willingness to switch to a biosimilar, with participants in the positive framing group being 2.36 times more willing to switch (P = 0.041). The positive framing group also reported significantly greater perceived efficacy of biosimilars (P = 0.046), and thought the explanation was more convincing (P = 0.030). The analogy did not enhance willingness to switch or understanding (P > 0.05).

Conclusion: Positive framing can improve perceptions of and willingness to switch to a biosimilar in patients currently taking biologic medications.


Disclosure: C. Gasteiger, None; A. Jones, None; M. Kleinstauber, None; M. Lobo, None; R. Horne, None; K. Petrie, None; N. Dalbeth, Abbvie, 5, 8, 9, Amgen, 2, AMGEN, 2, AstraZeneca, 2, 5, 8, 9, Dyve, 5, 8, 9, Dyve BioSciences, 5, Hengrui, 5, 8, 9, Horiaon, 5, 8, Horizon, 5, 8, 9, Janssen, 5, 8, 9, Kowa, 5, 8, 9, Pfizer, 5, 8, 9.

To cite this abstract in AMA style:

Gasteiger C, Jones A, Kleinstauber M, Lobo M, Horne R, Petrie K, Dalbeth N. The Effects of Message Framing on Patients’ Perceptions and Willingness to Switch to a Biosimilar [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-effects-of-message-framing-on-patients-perceptions-and-willingness-to-switch-to-a-biosimilar/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effects-of-message-framing-on-patients-perceptions-and-willingness-to-switch-to-a-biosimilar/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology